Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Arch Virol
5 Clin Infect Dis
2 Infect Immun
2 J Infect
2 J Pediatr
2 Lancet
4 MMWR Morb Mortal Wkly Rep
5 N Engl J Med
1 Nat Immunol
1 Nat Med
2 Pediatr Infect Dis J
1 Pediatrics
1 PLoS Med
11 PLoS One
3 Proc Natl Acad Sci U S A
3 Science
18 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Arch Virol

  1. JANG Y, Seo SH
    H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses.
    Arch Virol. 2021 Oct 25. pii: 10.1007/s00705-021-05284.
    PubMed         Abstract available


    The UK government's covid complacency shows lessons haven't been learned.
    BMJ. 2021;375:n2584.

    Covid-19: Vaccines are highly effective in preventing deaths from delta variant, study indicates.
    BMJ. 2021;375:n2582.

    Covid-19: Protect healthcare workers with vaccines, urges WHO after 115 000 die worldwide.
    BMJ. 2021;375:n2592.

    Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds.
    BMJ. 2021;375:n2623.

  6. DYER O
    Covid-19: US and China prepare for mass vaccination of children under 12.
    BMJ. 2021;375:n2631.

    Covid-19: global vaccine production is a mess and shortages are down to more than just hoarding.
    BMJ. 2021;375:n2375.

    Clin Infect Dis

  8. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    PubMed         Abstract available

  9. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2021 Oct 26. pii: 6410706. doi: 10.1093.

  10. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    PubMed         Abstract available

  11. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    PubMed         Abstract available

  12. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    PubMed         Abstract available

    Infect Immun

  13. GUO M, Guo X, Zhang C, Zhu S, et al
    A novel pneumococcal protein-polysaccharide conjugate vaccine based on biotin-streptavidin.
    Infect Immun. 2021 Oct 25:IAI0035221. doi: 10.1128/IAI.00352.
    PubMed         Abstract available

  14. TEIXEIRA AF, Gillespie A, Yirsaw A, Britton E, et al
    Identification of leptospiral protein antigens recognized by WC1(+) gammadelta T cell subsets as target for development of recombinant vaccines.
    Infect Immun. 2021 Oct 25:IAI0049221. doi: 10.1128/IAI.00492.
    PubMed         Abstract available

    J Infect

  15. CHONG Y, Tani N, Goto T, Yonekawa A, et al
    Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00508.

  16. GUPTA A, Bhoyar RC, Mirza S, Jolly B, et al
    SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.
    J Infect. 2021 Oct 19. pii: S0163-4453(21)00506.

    J Pediatr

  17. BARTON SM, Calhoun AW, Bohnert CA, Multerer SM, et al
    Standardized Vaccine-Hesitant Patients in the Assessment of the Effectiveness of Vaccine Communication Training.
    J Pediatr. 2021 Oct 23. pii: S0022-3476(21)01026.
    PubMed         Abstract available

  18. BROWN KL
    European pediatric societies and SARS-CoV-2 Vaccination in children under age 12: a different path in England.
    J Pediatr. 2021 Oct 18. pii: S0022-3476(21)00973.


  19. HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
    Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.

  20. USHER AD
    Vaccine shortages prompt changes to COVAX strategy.
    Lancet. 2021;398:1474.

    MMWR Morb Mortal Wkly Rep

  21. XU S, Huang R, Sy LS, Glenn SC, et al
    COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1520-1524.
    PubMed         Abstract available

  22. MUHOZA P, Danovaro-Holliday MC, Diallo MS, Murphy P, et al
    Routine Vaccination Coverage - Worldwide, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1495-1500.
    PubMed         Abstract available

  23. OLSON SM, Newhams MM, Halasa NB, Price AM, et al
    Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1483-1488.
    PubMed         Abstract available

  24. BLAU EF, Flinchum A, Gaub KL, Hartnett KP, et al
    Mycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations - Indiana, Kentucky, and Ohio, September 2018-February 2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:1472-1477.
    PubMed         Abstract available

    N Engl J Med

  25. RUBIN EJ, Baden LR, Wu KJ, Morrissey S, et al
    Audio Interview: Reporting on Covid-19.
    N Engl J Med. 2021;385:e66.

  26. DAGAN N, Barda N, Balicer RD
    Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMc2115045.

  27. GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
    Waning Immunity after the BNT162b2 Vaccine in Israel.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2114228.
    PubMed         Abstract available

    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.

  29. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
    N Engl J Med. 2021;385:e74.

    Nat Immunol

  30. NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.

    Nat Med

  31. PATONE M, Handunnetthi L, Saatci D, Pan J, et al
    Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection.
    Nat Med. 2021 Oct 25. pii: 10.1038/s41591-021-01556.
    PubMed         Abstract available

    Pediatr Infect Dis J

  32. QUINN HE, Comeau JL, Marshall HS, Elliott EJ, et al
    Pertussis Disease and Antenatal Vaccine Effectiveness in Australian Children.
    Pediatr Infect Dis J. 2021 Oct 26. pii: 00006454-900000000-95646.
    PubMed         Abstract available

  33. LEE JK
    Aseptic Meningitis Following the Second Dose of Comirnaty Vaccination in an Adolescent Patient: A Case Report.
    Pediatr Infect Dis J. 2021 Oct 26. pii: 00006454-900000000-95645.
    PubMed         Abstract available


  34. PERMAR S, Creech CB, Edwards KM, Walter EB, et al
    Proposals to Accelerate Novel Vaccine Development for Children.
    Pediatrics. 2021 Oct 22. pii: peds.2021-054593. doi: 10.1542/peds.2021-054593.

    PLoS Med

  35. BARRY H, Mutua G, Kibuuka H, Anywaine Z, et al
    Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
    PLoS Med. 2021;18:e1003813.
    PubMed         Abstract available

    PLoS One

  36. ELLIOTT T, Yehia BR, Winegar AL, Raja JK, et al
    Analysis of COVID-19 vaccine non-intent by essential vs non-essential worker, demographic, and socioeconomic status among 101,048 US adults.
    PLoS One. 2021;16:e0258540.
    PubMed         Abstract available

  37. GAO X, Wang L, Zhang H, Zhu B, et al
    Transcriptome analysis and identification of genes associated with floral transition and fruit development in rabbiteye blueberry (Vaccinium ashei).
    PLoS One. 2021;16:e0259119.
    PubMed         Abstract available

  38. ARGOTE TIRONI P, Barham E, Zuckerman Daly S, Gerez JE, et al
    Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2021;16:e0259059.
    PubMed         Abstract available

  39. BITAR AN, Zawiah M, Al-Ashwal FY, Kubas M, et al
    Misinformation, perceptions towards COVID-19 and willingness to be vaccinated: A population-based survey in Yemen.
    PLoS One. 2021;16:e0248325.
    PubMed         Abstract available

  40. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed         Abstract available

  41. TARIQ MH, Bhatti R, Ali NF, Ashfaq UA, et al
    Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach.
    PLoS One. 2021;16:e0258443.
    PubMed         Abstract available

  42. JANG H, Ross TM
    Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    PLoS One. 2021;16:e0258453.
    PubMed         Abstract available

  43. ENRIA L, Bangura JS, Kanu HM, Kalokoh JA, et al
    Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra Leone.
    PLoS One. 2021;16:e0258252.
    PubMed         Abstract available

  44. SOWE A, Njie M, Sowe D, Fofana S, et al
    Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    PLoS One. 2021;16:e0258961.
    PubMed         Abstract available

  45. ARNHEIM-DAHLSTROM L, Zarabi N, Hagen K, Bencina G, et al
    Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study.
    PLoS One. 2021;16:e0256642.
    PubMed         Abstract available

  46. LEONHARDT JM, Ridinger G, Rong Y, Talaei-Khoe A, et al
    Invincibility threatens vaccination intentions during a pandemic.
    PLoS One. 2021;16:e0258432.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  47. GUTIERREZ-ALVAREZ J, Honrubia JM, Sanz-Bravo A, Gonzalez-Miranda E, et al
    Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  48. XIA D, Jin R, Byagathvalli G, Yu H, et al
    An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  49. HUGHES MT, Auwaerter PG, Ehmann MR, Garibaldi BT, et al
    Opinion: The importance of offering vaccine choice in the fight against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.


  50. KRISHTEL P, Hassan F
    Share vaccine know-how.
    Science. 2021;374:379.
    PubMed         Abstract available

    Polio vaccination to resume across Afghanistan.
    Science. 2021;374:382.
    PubMed         Abstract available

  52. CORBETT KS, Gagne M, Wagner DA, O' Connell S, et al
    Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
    Science. 2021 Oct 21:eabl8912. doi: 10.1126/science.abl8912.
    PubMed         Abstract available


  53. HUMBLE RM, Sell H, Dube E, MacDonald NE, et al
    Canadian parents' perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01309.
    PubMed         Abstract available

  54. OPRIESSNIG T, Rawal G, McKeen L, Filippsen Favaro P, et al
    Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination.
    Vaccine. 2021 Oct 24. pii: S0264-410X(21)01353.
    PubMed         Abstract available

  55. CHANTHAVANICH P, Versage E, Van Twuijver E, Hohenboken M, et al
    Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01317.
    PubMed         Abstract available

  56. HUANG J, Bai Y, Ding H, Wang B, et al
    Acceptance of pneumococcal vaccination in older adults: A general population-based survey.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01344.
    PubMed         Abstract available

  57. CAPPOZZO F, Dal Zotto A, Scollo M, Bernardini D, et al
    dTap vaccination uptake during pregnancy: Pregnant women-focused and health professionals-focused predictors in the Veneto Region (Italy).
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01321.
    PubMed         Abstract available

    Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01371.
    PubMed         Abstract available

  59. LOEB M, Russell ML, Kelly-Stradiotto C, Fuller N, et al
    Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01355.
    PubMed         Abstract available

  60. MYAT TW, Thu HM, Tate JE, Burnett E, et al
    Rotavirus infection among children under five years of age hospitalized with acute gastroenteritis in Myanmar during 2018-2020 - Multicentre surveillance before rotavirus vaccine introduction.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01323.
    PubMed         Abstract available

  61. KIM D, Pekgun P, Yildirim I, Keskinocak P, et al
    Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01346.
    PubMed         Abstract available

  62. DANKWA EA, Donnelly CA, Brouwer AF, Zhao R, et al
    Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United states.
    Vaccine. 2021 Oct 19. pii: S0264-410X(21)01308.
    PubMed         Abstract available

  63. DANG TKNS, Rivero Cabrera R, Yeung KHT, van der Putten IM, et al
    Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months - 2 years and pregnant women.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01291.
    PubMed         Abstract available

  64. ABU-RAYA B, Maertens K, Munoz FM, Zimmermann P, et al
    Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.
    Vaccine. 2021;39:6545-6552.
    PubMed         Abstract available

  65. DAR SA, Kole S, Shin SM, Jeong HJ, et al
    Comparative study on antigen persistence and immunoprotective efficacy of intramuscular and intraperitoneal injections of squalene - aluminium hydroxide (Sq + Al) adjuvanted viral hemorrhagic septicaemia virus vaccine in olive flounder (Paralichthys o
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01345.
    PubMed         Abstract available

  66. VAN BEEK LF, Langereis JD, van den Berg van Saparoea HB, Gillard J, et al
    Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01313.
    PubMed         Abstract available

  67. SHUBITZ LF, Robb EJ, Powell DA, Bowen RA, et al
    Deltacps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01349.
    PubMed         Abstract available

  68. SHACHOR-MEYOUHAS Y, Hussein K, Szwarcwort-Cohen M, Weissman A, et al
    Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01327.
    PubMed         Abstract available

  69. FAN X, Li X, Wan K, Zhao X, et al
    Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01354.
    PubMed         Abstract available

  70. ANGSUWATCHARAKON P, Puthanakit T, Bunjoungmanee P, Anugulruengkitt S, et al
    High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
    Vaccine. 2021 Sep 20. pii: S0264-410X(21)01127.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.